Charles M. Balch
- Oncology top 0.01%
- Molecular Biology top 0.5%
- Immunology top 0.1%
- Epidemiology top 0.1%
- Dermatology top 0.05%
- Co-authors
- Toru AboMerrick I. RossJeffrey E. GershenwaldJohn F. ThompsonJohn M. KirkwoodSeng-Jaw SoongSeng‐Jaw SoongKelly M. McMasters
- Topics
- Cutaneous Melanoma Detection and Management (110 papers)Immunotherapy and Immune Responses (56 papers)Immune Cell Function and Interaction (40 papers)
- Cited by
- OncologyImmunologyDermatology
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Charles M. Balch
299 papers receiving 30.1k citations
Hit Papers
Peers
Comparison fields: 5 of 187
- Oncology 19.8k
- Molecular Biology 8.2k
- Immunology 7.7k
- Epidemiology 6.5k
- Dermatology 3.2k
Countries citing papers authored by Charles M. Balch
This map shows the geographic impact of Charles M. Balch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Balch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Balch more than expected).
Fields of papers citing papers by Charles M. Balch
This network shows the impact of papers produced by Charles M. Balch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Balch. The network helps show where Charles M. Balch may publish in the future.
Co-authorship network of co-authors of Charles M. Balch
This figure shows the co-authorship network connecting the top 25 collaborators of Charles M. Balch. A scholar is included among the top collaborators of Charles M. Balch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles M. Balch. Charles M. Balch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 22 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | Recommendations for the Role of Clinical Pathways in an Era of Personalized Medicine | 1 |
| 6 | 239 | |
| 7 | 1 | |
| 8 | 250 | |
| 9 | 287 | |
| 10 | Final Version of 2009 AJCC Melanoma Staging and Classificationbreakdown → | 3342 |
| 11 | 136 | |
| 12 | 41 | |
| 13 | 11 | |
| 14 | 2 | |
| 15 | Involvement of both Tac and non-Tac interleukin 2-binding peptides in the interleukin 2-dependent proliferation of human tumor-infiltrating lymphocytes. | 15 |
| 16 | 7 | |
| 17 | International Advances in Surgical Oncology, Volume 4 | 1 |
| 18 | Follow-Up of the Cancer Patient | 10 |
| 19 | 162 | |
| 20 | 38 |
About Charles M. Balch
Charles M. Balch is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 311 papers that have together received 31.4k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (110 papers), Immunotherapy and Immune Responses (56 papers) and Immune Cell Function and Interaction (40 papers). The work is most often cited by research in Oncology (19.8k citations), Immunology (7.7k citations) and Dermatology (3.2k citations). Charles M. Balch has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Toru Abo, Merrick I. Ross, Jeffrey E. Gershenwald, John F. Thompson, John M. Kirkwood, Seng-Jaw Soong, Seng‐Jaw Soong, Kelly M. McMasters, Daniel G. Coit and Tait D. Shanafelt. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.